Investor.
Builder.
Competitor.
Operator-grade discipline brought to European healthcare capital.
Read · 38 seconds
Last edited · April 2026
I treat capital with operator discipline. Eighteen years of product and growth work — Eurosport, WebMD Europe, Aescuvest — and now CFO at Aescuvest and CFO and GP at ACP HealthTech, backing European healthcare founders at Series A.
Preparation is the edge. Honest losses earn the next shot. Compounding reps beat bursts.
Patient capital for founders who treat the work as a practice.
The work is one game, played on three surfaces.
“Europe gets 15% of global healthtech capital. I see the decade's biggest arbitrage.”
Series A. EU or EU+US. Healthtech, medtech, AI for medicine, longevity, wellness. Clear mechanism of action; clear path to revenue.
Founder-market fit you can feel in the first ten minutes. Regulatory complexity as a moat, not a tax. Capital-efficient traction over theatrical spend.
CFO-grade financial sparring. An EU operator network most funds don't have. Honest feedback, fast.
A trophy case, kept honest.
The best ideas come from real conversations — no pitches, no decks, just two people.
Built slowly. On purpose.